Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
(NASDAQ: RLYB) Delayed: 16.62 +0.01 (0.06%)
Previous Close $16.61    52 Week High $ 
Open $16.80    52 Week Low $ 
Day High $17.07    P/E N/A 
Day Low $16.62    EPS $ 
Volume 7,027